Literature DB >> 9467718

The pathway of cell senescence: WI-38 cells arrest in late G1 and are unable to traverse the cell cycle from a true G0 state.

R J Pignolo1, B G Martin, J H Horton, A N Kalbach, V J Cristofalo.   

Abstract

Senescent human diploid fibroblasts have an undefined arrest state partially characterized by the differential expression of cell cycle-regulated genes and a failure to complete the mitogen-stimulated cascade of signalling events that lead to DNA synthesis. We present evidence that this arrest state precludes the entry of senescent fibroblasts into a normally reversible G0 or quiescent state. Both nuclear association kinetics and quinacrine dihydrochloride nuclear fluorescence show chromatin condensation patterns consistent with arrest in late G1 and exclusion of senescent cells from the G0 phase of the cell cycle. Steady-state thymidine kinase mRNA levels indicate that some of the signalling cascades initiated from a functional G0 state may be intact in senescent cells, at least qualitatively, and that this expression may represent an abortive attempt to complete pathways required for DNA replication. Taken together, the evidence suggests that growth arrest in senescent cells likely occurs in a physiologic state fundamentally distinct from that of the G0, quiescent state that is achieved by nonproliferating young cells. A full response to serum or growth factor addition, leading from quiescence to DNA synthesis, may require cells to initiate this traverse from a true G0 state. If so, senescent cells would be excluded from this pathway.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9467718     DOI: 10.1016/s0531-5565(97)00090-9

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  9 in total

1.  Senescence-specific gene expression fingerprints reveal cell-type-dependent physical clustering of up-regulated chromosomal loci.

Authors:  Hong Zhang; Kuang-Hung Pan; Stanley N Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-07       Impact factor: 11.205

2.  Mitogen stimulation cooperates with telomere shortening to activate DNA damage responses and senescence signaling.

Authors:  A Satyanarayana; R A Greenberg; S Schaetzlein; J Buer; K Masutomi; W C Hahn; S Zimmermann; U Martens; M P Manns; K L Rudolph
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

3.  Endothelial matrix assembly during capillary morphogenesis: insights from chimeric TagRFP-fibronectin matrix.

Authors:  Fumin Chang; Christopher A Lemmon; Voraphoj Nilaratanakul; Varda Rotter; Lewis Romer
Journal:  J Histochem Cytochem       Date:  2014-07-25       Impact factor: 2.479

Review 4.  Targeting Cell Senescence for the Treatment of Age-Related Bone Loss.

Authors:  Robert J Pignolo; Rebekah M Samsonraj; Susan F Law; Haitao Wang; Abhishek Chandra
Journal:  Curr Osteoporos Rep       Date:  2019-04       Impact factor: 5.096

Review 5.  Cellular senescence and organismal aging.

Authors:  Jessie C Jeyapalan; John M Sedivy
Journal:  Mech Ageing Dev       Date:  2008-04-12       Impact factor: 5.432

6.  Long-term quiescent fibroblast cells transit into senescence.

Authors:  Shiva Marthandan; Steffen Priebe; Peter Hemmerich; Karolin Klement; Stephan Diekmann
Journal:  PLoS One       Date:  2014-12-22       Impact factor: 3.240

7.  Raman and infrared spectroscopy reveal that proliferating and quiescent human fibroblast cells age by biochemically similar but not identical processes.

Authors:  Katharina Eberhardt; Christian Matthäus; Shiva Marthandan; Stephan Diekmann; Jürgen Popp
Journal:  PLoS One       Date:  2018-12-03       Impact factor: 3.240

Review 8.  Bone Aging, Cellular Senescence, and Osteoporosis.

Authors:  Robert J Pignolo; Susan F Law; Abhishek Chandra
Journal:  JBMR Plus       Date:  2021-04-02

9.  Saccharomyces cerevisiae as a Model to Study Replicative Senescence Triggered by Telomere Shortening.

Authors:  M Teresa Teixeira
Journal:  Front Oncol       Date:  2013-04-26       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.